24 results
8-K
EX-10.1
EMMA
Emmaus Life Sciences, Inc.
16 Feb 21
Entry into a Material Definitive Agreement
4:09pm
or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials
8-K
EX-1.1
EMMA
Emmaus Life Sciences, Inc.
3 Mar 20
Emmaus Life Sciences Announces Equity Purchase Agreement for up to $25 Million with Lincoln Park Capital
10:58am
applicable foreign, federal, state and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic
424B3
920iixew
14 Jun 19
Prospectus supplement
2:02pm
S-4/A
g63xufq11jfuj2
10 Jun 19
Registration of securities issued in business combination transactions (amended)
5:29pm
425
EX-10.1
nnebllbyjl
23 May 19
Business combination disclosure
8:36am
8-K
EX-10.1
t562lu
23 May 19
MYnd Analytics Announces $2.8 Million Registered Direct Offering
8:34am
8-K
EX-2.1
eygc8yr0f1e80wt5hk8g
7 Jan 19
MYnd Analytics and Emmaus Life Sciences Announce Merger and Spin-off Transaction
8:00am
425
EX-2.1
56js3zs1cdvi
7 Jan 19
Business combination disclosure
7:58am
8-K
EX-10.1
7sgz9a
18 May 18
Entry into a Material Definitive Agreement
5:13pm
10-K
4hgfywu
13 Jan 09
Annual report
12:00am
POS AM
rybrp3l8
10 Mar 08
Prospectus update (post-effective amendment)
12:00am
8-K
2p2d3hi7
13 Mar 07
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10
y2l khomr
24 Jul 06
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2
ikqaa3nafbngwzo76c
24 Jun 04
Acquisition or disposition of assets
12:00am